Understanding how midlife risk factors influence age at onset (AAO) of Alzheimer’s disease (AD) may provide clues to delay disease expression. Although midlife adiposity predicts increased incidence of AD, it is unclear whether it affects AAO and severity of Alzheimer’s neuropathology. Using a prospective population-based cohort, Baltimore Longitudinal Study of Aging (BLSA), this study aims to examine the relationships between midlife body mass index (BMI) and (1) AAO of AD (2) severity of Alzheimer’s neuropathology and (3) fibrillar brain amyloid deposition during aging. We analyzed data on 1394 cognitively normal individuals at baseline (8643 visits; average follow-up interval 13.9 years), among whom 142 participants developed incident AD. In two subsamples of BLSA, 191 participants underwent autopsy and neuropathological assessment, and 75 non-demented individuals underwent brain amyloid imaging. Midlife adiposity was derived from BMI data at 50 years of age. We find that each unit increase in midlife BMI predicts earlier onset of AD by 6.7 months (P=0.013). Higher midlife BMI was associated with greater Braak neurofibrillary but not CERAD (Consortium to Establish a Registry for Alzheimer's Disease) neuritic plaque scores at autopsy overall. Associations between midlife BMI and brain amyloid burden approached statistical significance. Thus, higher midlife BMI was also associated with greater fibrillar amyloid measured by global mean cortical distribution volume ratio (P=0.075) and within the precuneus (left, P=0.061; right, P=0.079). In conclusion, midlife overweight predicts earlier onset of AD and greater burden of Alzheimer’s neuropathology. A healthy BMI at midlife may delay the onset of AD.
Subscribe to Journal
Get full journal access for 1 year
only $41.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Barnes DE, Yaffe K . The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 2011; 10: 819–828.
Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM . Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007; 3: 186–191.
Brookmeyer R, Gray S, Kawas C . Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998; 88: 1337–1342.
Lourida I, Soni M, Thompson-Coon J, Purandare N, Lang IA, Ukoumunne OC et al. Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology 2013; 24: 479–489.
Radak Z, Hart N, Sarga L, Koltai E, Atalay M, Ohno H et al. Exercise plays a preventive role against Alzheimer's disease. J Alzheimers Dis 2010; 20: 777–783.
Hassing LB, Dahl AK, Thorvaldsson V, Berg S, Gatz M, Pedersen NL et al. Overweight in midlife and risk of dementia: a 40-year follow-up study. Int J Obes (Lond) 2009; 33: 893–898.
Anstey KJ, Cherbuin N, Budge M, Young J . Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev 2011; 12: e426–e437.
Beydoun MA, Beydoun HA, Wang Y . Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev 2008; 9: 204–218.
Beydoun MA, Lhotsky A, Wang Y, Dal Forno G, An Y, Metter EJ et al. Association of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer's disease. Am J Epidemiol 2008; 168: 1179–1189.
Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O'Meara ES, Longstreth WT Jr et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 2009; 66: 336–342.
Tolppanen AM, Ngandu T, Kareholt I, Laatikainen T, Rusanen M, Soininen H et al. Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort. J Alzheimers Dis 2014; 38: 201–209.
Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr, Yaffe K . Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 2005; 330: 1360.
Ford ES, Mokdad AH . Epidemiology of obesity in the Western Hemisphere. J Clin Endocrinol Metab 2008; 93 (Suppl 1): S1–S8.
Kelly T, Yang W, Chen CS, Reynolds K, He J . Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008; 32: 1431–1437.
Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK . Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring, MD) 2008; 16: 2323–2330.
Shock NW, Gruelich R, Andres R, Arenberg D, Costa PT, Lakatta E et al. Normal Human Aging. The Baltimore Longitudinal Study of Aging, US Government Printing Office: Washington, DC, USA, 1984.
Ferrucci L . The Baltimore Longitudinal Study of Aging (BLSA): a 50-year-long journey and plans for the future. J Gerontol A 2008; 63: 1416–1419.
Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A . Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 2000; 54: 2072–2077.
American Psychiatric Association APAWGtRDSM, III Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R. American Psychiatric Association: : Washington, DC, 1987.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939–944.
Petersen RC . Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183–194.
O'Brien RJ, Resnick SM, Zonderman AB, Ferrucci L, Crain BJ, Pletnikova O et al. Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA). J Alzheimers Dis 2009; 18: 665–675.
Gamaldo A, Moghekar A, Kilada S, Resnick SM, Zonderman AB, O'Brien R . Effect of a clinical stroke on the risk of dementia in a prospective cohort. Neurology 2006; 67: 1363–1369.
Troncoso JC, Zonderman AB, Resnick SM, Crain B, Pletnikova O, O'Brien RJ . Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Ann Neurol 2008; 64: 168–176.
Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al. The Consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479–486.
Braak H, Braak E . Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239–259.
Resnick SM, Goldszal AF, Davatzikos C, Golski S, Kraut MA, Metter EJ et al. One-year age changes in MRI brain volumes in older adults. Cereb Cortex 2000; 10: 464–472.
Sojkova J, Zhou Y, An Y, Kraut MA, Ferrucci L, Wong DF et al. Longitudinal patterns of beta-amyloid deposition in nondemented older adults. Arch Neurol 2011; 68: 644–649.
Fischl B . FreeSurfer. Neuroimage 2012; 62: 774–781.
McAuliffe MJ, Lalonde FM, McGarry D, Gandler W, Csaky K, Trus BL . Medical image processing, analysis and visualization in clinical research. In: Fourteenth IEEE Symposium On Computer-based Medical Systems. Washington, DC, USA 2001.
Lucas BC, Bogovic JA, Carass A, Bazin PL, Prince JL, Pham DL et al. The Java Image Science Toolkit (JIST) for rapid prototyping and publishing of neuroimaging software. Neuroinformatics 2010; 8: 5–17.
Ashburner J, Friston KJ . Spatial transformation of images. In: Frackowiak RSJ, Friston KJ, Frith C, Dolan R, Mazziotta JC . Human Brain Function. Academic Press: New York, NY, USA, 1997.
Jenkinson M, Bannister P, Brady M, Smith S . Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002; 17: 825–841.
Zhou Y, Endres CJ, Brasic JR, Huang SC, Wong DF . Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model. Neuroimage 2003; 18: 975–989.
Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004; 55: 306–319.
Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH et al. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006; 67: 446–452.
Carroll RJ . Measurement Error in Nonlinear Models : A Modern Perspective. Chapman & Hall/CRC: : London, UK, 2006.
Swindell WR . Accelerated failure time models provide a useful statistical framework for aging research. Exp Gerontol 2009; 44: 190–200.
Singh B, Parsaik AK, Mielke MM, Erwin PJ, Knopman DS, Petersen RC et al. Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis 2014; 39: 271–282.
Carlson MC, Helms MJ, Steffens DC, Burke JR, Potter GG, Plassman BL . Midlife activity predicts risk of dementia in older male twin pairs. Alzheimers Dement 2008; 4: 324–331.
Farrell SW, Finley CE, Radford NB, Haskell WL . Cardiorespiratory fitness, body mass index, and heart failure mortality in men: Cooper Center Longitudinal Study. Circ Heart Fail 2013; 6: 898–905.
Rovio S, Kareholt I, Helkala EL, Viitanen M, Winblad B, Tuomilehto J et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol 2005; 4: 705–711.
Sabia S, Singh-Manoux A, Hagger-Johnson G, Cambois E, Brunner EJ, Kivimaki M . Influence of individual and combined healthy behaviours on successful aging. CMAJ 2012; 184: 1985–1992.
Akushevich I, Kravchenko J, Ukraintseva S, Arbeev K, Kulminski A, Yashin AI . Morbidity risks among older adults with pre-existing age-related diseases. Exp Gerontol 2013; 48: 1395–1401.
Gillette-Guyonnet S, Nourhashemi F, Andrieu S, de Glisezinski I, Ousset PJ, Riviere D et al. Weight loss in Alzheimer disease. Am J Clin Nutr 2000; 71: 637S–642S.
Driscoll I, Beydoun MA, An Y, Davatzikos C, Ferrucci L, Zonderman AB et al. Midlife obesity and trajectories of brain volume changes in older adults. Hum Brain Mapp 2012; 33: 2204–2210.
Das UN . Is obesity an inflammatory condition? Nutrition 2001; 17: 953–966.
Purkayastha S, Cai D . Neuroinflammatory basis of metabolic syndrome. Mol Metab 2013; 2: 356–363.
We are grateful to the Baltimore Longitudinal Study of Aging participants and neuroimaging staff for their dedication to these studies and the staff of the Johns Hopkins University PET facility for their assistance. This work was supported in part by research and development contract HHSN-260-2004-00012C and the Intramural Research Program, National Institute on Aging, National Institutes of Health.
The authors declare no conflict of interest.
Supplementary Information accompanies the paper on the Molecular Psychiatry website
About this article
Cite this article
Chuang, Y., An, Y., Bilgel, M. et al. Midlife adiposity predicts earlier onset of Alzheimer’s dementia, neuropathology and presymptomatic cerebral amyloid accumulation. Mol Psychiatry 21, 910–915 (2016). https://doi.org/10.1038/mp.2015.129
Factors Predicting the Onset of Amnestic Mild Cognitive Impairment or Alzheimer's Dementia in Persons With Subjective Cognitive Decline
Journal of Gerontological Nursing (2020)
Sex-Specific Association of Lifetime Body Mass Index with Alzheimer’s Disease Neuroimaging Biomarkers
Journal of Alzheimer's Disease (2020)
Obesity Reviews (2020)
Body Weight Variability Increases Dementia Risk Among Older Adults: A Nationwide Population-Based Cohort Study
Frontiers in Endocrinology (2020)